Nayax president exercises options, sells 4,500 shares

Nayax Ltd. reported that President Sharir Keren executed an option exercise-and-sell sequence on May 27, 2026.

Rhea-AI Filing Summary

Nayax Ltd. reported that President Sharir Keren executed an option exercise-and-sell sequence on May 27, 2026. He exercised stock options for 4,500 Ordinary Shares at an exercise price of $6.70 per share, then sold 4,500 Ordinary Shares in two transactions at weighted average prices of $72.18 and $71.32 on the Tel Aviv Stock Exchange, with prices translated from ILS to USD. After these transactions, Keren directly holds 26,876 Ordinary Shares.

Insights

Equity compensation analyst

Routine option exercise with same-day share sales; modest net reduction in equity exposure.

Sharir Keren exercised stock options for 4,500 Ordinary Shares at an exercise price of $6.70, then sold the same number of shares in open-market trades at prices above $71. This is a classic exercise-and-sell pattern converting option value into cash.

The filing shows 0 remaining derivatives for this grant in the derivativeSummary, meaning this option position was fully exercised. He still holds 31,376 Ordinary Shares directly plus 23,100 remaining options from other grants, indicating continued equity exposure to Nayax Ltd.

The transactions were executed on the Tel Aviv Stock Exchange in ILS and reported in USD at the applicable exchange rate. No Rule 10b5-1 trading plan is mentioned, so the timing appears discretionary, but the scale and pattern are consistent with routine liquidity from equity compensation rather than a transformational position change.

Insider Trade Summary

Exercise and Sale: 4,500 shares ($293K approx. pre-tax spread)

Exercise and Sale 4 txns

Insider Sharir Keren

Role President

Sold 4,500 shs ($323K)

Approx. gross sale proceeds $323K

Approx. exercise cost $30K

Approx. pre-tax spread $293K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	4,500	$0.00	$0.00
Exercise	Ordinary Shares	4,500	$6.70	$30K
Sale	Ordinary Shares	2,500	$72.18	$180K
Sale	Ordinary Shares	2,000	$71.32	$143K

Holdings After Transaction: Stock Option (Right to Buy) — 23,100 contracts (Direct); Ordinary Shares — 26,876 shares (Direct)

Footnotes (5)

1. F1. The shares were acquired upon the exercise of stock options
2. F2. The shares sold were acquired upon the exercise of stock options on the same date
3. F3. These shares were sold in transactions on the Tel Aviv Stock Exchange in New Israeli Shekels (ILS) and have been converted to U.S. Dollars (USD) using the exchange rate in effect on the transaction date.
4. F4. The reported price is a weighted average price. These shares were sold in transactions on the Tel Aviv Stock Exchange in New Israeli Shekels (ILS) and have been converted to U.S. Dollars (USD) using the exchange rate in effect on the transaction date. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request
5. F5. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.

Key Figures

Options exercised: 4,500 Ordinary Shares Exercise price: $6.70 per share Shares sold (first block): 2,500 shares at $72.18 +4 more

7 metrics

Options exercised 4,500 Ordinary Shares Stock options exercised on 2026-05-27 into Ordinary Shares

Exercise price $6.70 per share Exercise or conversion price of stock options exercised on 2026-05-27

Shares sold (first block) 2,500 shares at $72.18 First sale of Ordinary Shares on 2026-05-27, weighted average USD price

Shares sold (second block) 2,000 shares at $71.32 Second sale of Ordinary Shares on 2026-05-27, weighted average USD price

Total shares sold 4,500 Ordinary Shares Aggregate Ordinary Shares sold on 2026-05-27 following option exercise

Post-transaction holdings 26,876 Ordinary Shares Direct Ordinary Shares held by Sharir Keren after reported transactions

Option expiration date 2026-12-31 Expiration date of the exercised stock options

Key Terms

Stock Option (Right to Buy), weighted average price, Tel Aviv Stock Exchange, New Israeli Shekels (ILS), +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

weighted average price financial

"The reported price is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Tel Aviv Stock Exchange market

"These shares were sold in transactions on the Tel Aviv Stock Exchange"

The Tel Aviv Stock Exchange is Israel’s main marketplace where stocks, bonds and exchange-traded funds are bought and sold, providing a centralized place for investors to trade ownership in companies and government debt. It matters because it sets real-time prices and liquidity for Israeli securities, offering a barometer of the country’s corporate health and giving investors a way to enter or exit positions much like an auction house or farmers’ market sets the price for goods.

New Israeli Shekels (ILS) financial

"transactions ... in New Israeli Shekels (ILS) and have been converted"

Rule 10b5-1 regulatory

"Rule 10b5-1 checkbox indicating trading plan status"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Nayax (NYAX) President Sharir Keren do in this Form 4?

President Sharir Keren exercised stock options for 4,500 Ordinary Shares at $6.70 per share and sold the same 4,500 shares in two transactions on May 27, 2026, while retaining a direct stake in the company.

How many Nayax (NYAX) shares did Sharir Keren sell and at what prices?

Sharir Keren sold 4,500 Ordinary Shares in total, split into 2,500 shares at a weighted average price of $72.18 and 2,000 shares at $71.32, with prices converted from trades on the Tel Aviv Stock Exchange.

What options did Nayax (NYAX) President Sharir Keren exercise?

He exercised a Stock Option (Right to Buy) for 4,500 Ordinary Shares at an exercise price of $6.70 per share. The options had an expiration date of December 31, 2026, and the underlying shares were then sold the same day.

How many Nayax (NYAX) shares does Sharir Keren hold after these transactions?

After the reported transactions, Sharir Keren directly holds 26,876 Ordinary Shares of Nayax Ltd. This figure represents his post-transaction direct ownership position as reported in the disclosure’s canonical holdings data.

On which exchange were the Nayax (NYAX) shares sold and in which currency?

The shares were sold on the Tel Aviv Stock Exchange in New Israeli Shekels (ILS). The reported per-share sale prices of $72.18 and $71.32 reflect conversion into U.S. Dollars (USD) using the exchange rate on the transaction date.

Were Nayax (NYAX) President Sharir Keren’s trades under a Rule 10b5-1 plan?

The disclosure’s Rule 10b5-1 checkbox is not marked as an affirmatively adopted trading plan, and the footnotes do not state that these transactions were executed pursuant to any pre-arranged Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/28/2026 - 07:12 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sharir Keren

(Last) (First) (Middle)

ARIK EINSTEIN 3

BUILDING B, FLOOR 1

(Street)

HERZLIYA

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nayax Ltd. [ NYAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	05/27/2026		M		4,500(1)	A	$6.7	31,376	D
Ordinary Shares	05/27/2026		S		2,500(2)	D	$72.18(3)	28,876	D
Ordinary Shares	05/27/2026		S		2,000(2)	D	$71.32(4)	26,876	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$6.7	05/27/2026		M(5)			4,500	07/01/2020	12/31/2026	Ordinary Shares	4,500	$0	23,100	D

Explanation of Responses:

1. The shares were acquired upon the exercise of stock options

2. The shares sold were acquired upon the exercise of stock options on the same date

3. These shares were sold in transactions on the Tel Aviv Stock Exchange in New Israeli Shekels (ILS) and have been converted to U.S. Dollars (USD) using the exchange rate in effect on the transaction date.

4. The reported price is a weighted average price. These shares were sold in transactions on the Tel Aviv Stock Exchange in New Israeli Shekels (ILS) and have been converted to U.S. Dollars (USD) using the exchange rate in effect on the transaction date. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request

5. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.

	/s/ Netta Cohen on behalf of Oppenheimer Israel, as Attorney-in-fact	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)